Ascendis Pharma A/S (ASND)
239.88
-25.04
(-9.45%)
USD |
NASDAQ |
Sep 15, 16:00
239.50
-0.38
(-0.16%)
After-Hours: 20:00
Ascendis Pharma Price to Book Value : 9.592 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 10.59 |
| September 11, 2026 | 10.54 |
| September 10, 2026 | 10.45 |
| September 09, 2026 | 10.43 |
| September 08, 2026 | 10.80 |
| September 04, 2026 | 10.82 |
| September 03, 2026 | 10.84 |
| September 02, 2026 | 10.69 |
| September 01, 2026 | 10.41 |
| August 31, 2026 | 10.52 |
| August 28, 2026 | 9.913 |
| August 27, 2026 | 9.971 |
| August 26, 2026 | 10.01 |
| August 25, 2026 | 10.12 |
| August 24, 2026 | 10.07 |
| August 21, 2026 | 10.13 |
| August 20, 2026 | 10.19 |
| August 19, 2026 | 10.38 |
| August 18, 2026 | 9.951 |
| August 17, 2026 | 9.893 |
| August 14, 2026 | 9.937 |
| August 13, 2026 | 9.846 |
| August 12, 2026 | 10.22 |
| August 11, 2026 | 10.18 |
| August 10, 2026 | 10.22 |
| Date | Value |
|---|---|
| August 07, 2026 | 10.21 |
| August 06, 2026 | 9.991 |
| August 05, 2026 | 9.765 |
| August 04, 2026 | 9.781 |
| August 03, 2026 | 9.735 |
| July 31, 2026 | 9.753 |
| July 30, 2026 | 10.04 |
| July 29, 2026 | 10.08 |
| July 28, 2026 | 10.17 |
| July 27, 2026 | 10.13 |
| July 24, 2026 | 10.15 |
| July 23, 2026 | 10.10 |
| July 22, 2026 | 10.07 |
| July 21, 2026 | 10.20 |
| July 20, 2026 | 10.07 |
| July 17, 2026 | 10.44 |
| July 16, 2026 | 10.39 |
| July 15, 2026 | 10.74 |
| July 14, 2026 | 10.62 |
| July 13, 2026 | 10.61 |
| July 10, 2026 | 10.81 |
| July 09, 2026 | 11.01 |
| July 08, 2026 | 11.08 |
| July 07, 2026 | 10.68 |
| July 06, 2026 | 10.71 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Evaxion AS | 2.669 |
| BioMarin Pharmaceutical, Inc. | 1.972 |
| Genmab A/S | 3.423 |
| Zealand Pharma A/S | 1.090 |
| Cellectis SA | 3.948 |
Price to Book Value Related Metrics
| PE Ratio | 18.28 |
| PS Ratio | 12.53 |
| Price to Free Cash Flow | 39.33 |
| Price | 239.88 |
| Earnings Yield | 5.47% |
| Market Cap | 15.75B |
| Operating PE Ratio | 121.41 |
| Normalized PE Ratio | 18.28 |